Anton Rets
No Rating Available
(Learn About Our Rating System)

Anton Rets, MD, PhD

Languages spoken: English, Russian

Dr. Rets is an associate professor of pathology at the University of Utah School of Medicine. He received his MD and PhD at Perm State Academy of Medicine in Russia.

He served as an anatomical and clinical pathology resident at State University of New York Health Science Center at Brooklyn and a hematopathology fellow at the University of Utah School of Medicine. Dr. Rets is board certified in hematopathology, anatomic pathology, and clinical pathology.

He is also a member of several professional societies, including the College of American Pathologists and the American Society for Clinical Pathology. Dr. Rets' professional interests include red blood cell disorders, non-neoplastic hematology, and myeloproliferative neoplasms.

Specialties

  • Hematopathology

Board Certification

American Board of Pathology (Sub: Hematopathology)
American Board of Pathology (Anatomic & Clinical)

Dr. Rets is an associate professor of pathology at the University of Utah School of Medicine. He received his MD and PhD at Perm State Academy of Medicine in Russia.

He served as an anatomical and clinical pathology resident at State University of New York Health Science Center at Brooklyn and a hematopathology fellow at the University of Utah School of Medicine. Dr. Rets is board certified in hematopathology, anatomic pathology, and clinical pathology.

He is also a member of several professional societies, including the College of American Pathologists and the American Society for Clinical Pathology. Dr. Rets' professional interests include red blood cell disorders, non-neoplastic hematology, and myeloproliferative neoplasms.

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Pathology (Sub: Hematopathology)
American Board of Pathology (Anatomic & Clinical)

Education history

Professional Medical Medicine - Perm State Medical Academy M.D.
Residency Pathology - Perm State Medical Academy Resident
Doctoral Training Pathology - Perm State Medical Academy/St. Petersburg Academy of Postgraduate Medical Education, Ph.D.
Residency Anatomical/Clinical Pathology - State University of New York Downstate Health Science Center at Brooklyn Resident
Chief Resident Pathology - State University of New York Downstate Health Science Center at Brooklyn Chief Resident
Fellowship Hematopathology - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Siebenhaar F, Broesby-Olsen S, Castells M, George TI, Livideanu CB, Alvarez-Twose I, Panse J, Barete S, Reiter A, Dybedal I, Akin C, Van Daele P, Radia DH, Cerquozzi S, Ustun C, Sabato V, Gotlib J, Rafferty M, DeAngelo DJ, Schafhausen P, Ungerstedt J, Ogbogu PU, Florell S, Wada DA, Rets A, Lin HM, Bidollari I, Hong J, Shaheen D, Lampson B, Hartmann (2026). Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study. Journal of the American Academy of Dermatology,
  2. Shestakova A, Rets AV, Menon (2025). Autoimmune Hepatobiliary Disease and Cryoglobulins in Peripheral Blood. American journal of hematology, 100(12), 2373-2374.
  3. Shean RC, Hellwig S, Saadalla A, George TI, Rets A (2025). High-sensitivity KIT D816V variation analysis by droplet digital polymerase chain reaction: The reference laboratory perspective. American journal of clinical pathology,
  4. Maccio U, Rets A, Grosse C, Ferguson NA, Langer R, Bühler MM, Gallo A, Witzel I, Beham-Schmid C, Wieler J, Orsaria M, Varga (2025). Clinical and pathological features of lymphomas in the breast: a comprehensive multicentric study. Scientific reports, 15(1), 29032.
  5. Shean R, Deshmukh N, Palmer M, Agarwal A, Rets (2025). Utility of Molecular Sequencing and Hematologic Parameters for Diagnosis of ¿-Thalassemia: A Perspective of the National Reference Laboratory. Hemoglobin, 1-7.
  6. Shean RC, Agarwal A, Rets A (2025). Unstable Hemoglobin, a Rare but Significant Cause of Hemolytic Anemia: Recognition of Peripheral Smear Findings Is Crucial for Diagnosis. International journal of laboratory hematology,
  7. Rets AV, George T (2024). How I diagnose systemic mastocytosis. American journal of clinical pathology,
  8. Vardell VA, Ose J, Rets AV, Tantravahi SK, Patel A (2024). Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis. Clinical lymphoma, myeloma & leukemia, 24(12), 843-851.
  9. Zhukovsky S, Rets A, Braaten T, Patel A (2024). VEXAS without vacuoles: Linking genotype to phenotype. EJHaem, 5(5), 981-986.
  10. Agarwal AM, McMurty V, Clayton AL, Bolia A, Reading NS, Mani C, Patel JL, Rets (2023). Clinical utility of targeted next-generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience. European journal of haematology, 110(6), 688-695.
  11. Liew M, Rowe L, Moore K, Aston E, O'Brien K, Longhurst M, Kenney J, Priest M, Zhou W, Wilcock D, Rets A, Miles (2023). Validation of MYC and BCL6 rapid break apart digital fluorescence in situ hybridization assays for clinical use. International journal of clinical and experimental pathology, 16(4), 76-85.
  12. Ramia de Cap M, Wu LP, Hirt C, Pihan GA, Patel SS, Tam W, Bueso-Ramos CE, Kanagal-Shamanna R, Raess PW, Siddon A, Narayanan D, Morgan EA, Pinkus GS, Mason EF, Hsi ED, Rogers HJ, Toth L, Foucar K, Hurwitz SN, Bagg A, Rets A, George TI, Orazi A, Arber DA, Hasserjian RP, Weinberg OK, Bone Marrow Pathology Grou (2023). Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leukemia & lymphoma, 1-9.
  13. Al-Ghamdi YA, Lake J, Bagg A, Thakral B, Wang SA, Bueso-Ramos C, Masarova L, Verstovsek S, Rogers HJ, Hsi ED, Gralewski JH, Chabot-Richards D, George TI, Rets A, Hasserjian RP, Weinberg OK, Parilla M, Arber DA, Padilla O, Orazi A, Tam (2023). Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology, 36(3), 100016.
  14. Maccio U, Rets A (2022). Lymphoid aggregates in bone marrow: a diagnostic pitfall. Journal of clinical pathology, 75(12), 807-814.
  15. Agarwal AM, Rets (2021). Laboratory approach to investigation of anemia in pregnancy. International journal of laboratory hematology, 43 Suppl 1, 65-70.
  16. Rets AV, Reading NS, Agarwal A (2020). ¿-Globin Chain Variants Associated with Decreased Hb A2 Levels: A National Reference Laboratory Experience. Hemoglobin, 44(6), 438-441.
  17. Agarwal AM, Rets (2020). Laboratory approach to investigation of anemia with a focus on pyruvate kinase deficiency. International journal of laboratory hematology, 42 Suppl 1, 107-112.
  18. Rets A, Clayton AL, Christensen RD, Agarwal A (2019). Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia. International journal of laboratory hematology, 41 Suppl 1, 95-101.
  19. Toydemir RM,Rets AV,Hussong JW,Atanackovic D,Salama M (2018). Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant. Journal of hematopathology, 11(3), 75-80.
  20. Gangaraju R, Rets A, Smock KJ, Heikal N (2017). Rare complication of treated immune thrombocytopenia. American journal of hematology, 92(11), 1262-1266.
  21. Harper A, Lu C, Sun Y, Garcia R, Rets A, Alexis H, Saad H, Eid I, Harris L, Marshall B, Tafani E, Pincus M (2016). Reproducibility of Serum Potassium Values in Serum From Blood Samples Stored for Increasing Times Prior to Centrifugation and Analysis. Journal of clinical laboratory analysis, 30(3), 244-7.
  22. Rets AV, Gottesman S (2014). Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge. Case reports in pathology, 2014, 956217.
  23. Qin J, Wang H, Rets A, Harari S, Alexis H, Eid I, Pincus M (2013). Stability of BUN and creatinine determinations on the Siemens Advia 1800 analyzer. Journal of clinical laboratory analysis, 27(6), 435-7.
  24. Rets A, Gupta R, Haseeb M (2013). Determinants of reactivation of inapparent Strongyloides stercoralis infection in patients hospitalized for unrelated admitting diagnosis. European journal of gastroenterology & hepatology, 25(11), 1279-85.
  25. Friend GG, Kruchkov AN, Rets A (2004). Comparative Characteristic of Axillary Lymph Nodes in Breast Carcinoma Patients with and without Radiotherapy. (3), 56-8.
  26. Patrikeev IA, Kruchkov AN, Friend GG, Yurlov RA, Rets A (2004). Usage of wavelet filtration for assessment of nuclear pleomorphism in invasive ductal carcinoma of the breast. 8(4), 91-6.

Review

  1. Shestakova G, Edgar NU, Rets A (2025). Common Hematologic Emergencies-Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias-A Pivotal Role of Clinical Laboratory. International journal of laboratory hematology,
  2. Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter M (2025). Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. American journal of clinical dermatology, 26(4), 499-510.
  3. Genzen JR, Miller LJ, Rets AV, Affolter K (2025). Laboratory-developed tests and in vitro diagnostics: A regulatory overview for anatomic pathology. American journal of clinical pathology, 163(5), 730-743.
  4. Shean RC, Rets A (2025). Digital Pathology in Hematopathology: From Vision to Deployment. International journal of laboratory hematology,
  5. Rets A, George T (2025). Diagnosing Systemic Mastocytosis: State of the Art. International journal of laboratory hematology,
  6. Dadelahi A, Jackson T, Agarwal AM, Lin L, Rets AV, Ng D (2024). Applications of Flow Cytometry in Diagnosis and Evaluation of Red Blood Cell Disorders. Clinics in laboratory medicine, 44(3), 495-509.
  7. Agarwal AM, Rets A (2024). Advances in Hemoglobinopathies and Thalassemia Evaluation. Clinics in laboratory medicine, 44(3), 441-453.
  8. Shean RC, Williams MC, Rets A (2024). Advances in Hematology Analyzers Technology. Clinics in laboratory medicine, 44(3), 377-386.
  9. Agarwal AM, Rets A (2023). Molecular diagnosis of hereditary hemolytic anemias: Recent updates. International journal of laboratory hematology, 45 Suppl 2, 79-86.
  10. Maccio U, Gianolio A, Rets A (2023). Granulomas in bone marrow biopsies: clinicopathological significance and new perspectives. Journal of clinical pathology,

Book Chapter

  1. Rets AV, Agarwal A (2024). Chapter 8: Using Targeted Genetic Panels to Find the Causes of Neonatal hemolytic anemia. 91-102.
  2. Rets (2008). Death. Necrosis. Apoptosis. Degeneration.
  3. Friend GG, Kruchkov AN, Rets A (2004). Morphological Diagnostics of Radiogenic Changes in Lymph Nodes Manual.
  4. Agarwal A, Rets Disorders of hemoglobin synthesis, thalassemias and structural hemoglobinopathies.

Case Report

  1. Simpson SJ, Lim MY, George TI, Rets (2021). 36-year-old male with X-linked congenital sideroblastic anemia presenting as chronic microcytic anemia with iron overload. International journal of laboratory hematology, 44(1), 69-71.
  2. Rets AV, Eid I, Lutwick L, Pincus M (2012). Parotid gland abscess caused by Haemophilus paraphrophilus: a case report. Annals of clinical and laboratory science, 42(4), 422-3.

Letter

  1. Agarwal AM, Rets A, Mani (2025). Novel Mutations in SUPT5H Gene Associated With Beta-Thalassemia Phenotype. International journal of laboratory hematology, 47(3), 552-554.
  2. Osman AEG, Rets A, Patel A (2024). KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia. Leukemia research, 138, 107466.
  3. Meznarich JA, Rets A, Agarwal AM, Christensen RD, Reading NS, Kuypers FA, Prchal J (2021). Novel, de novo, beta-globin variant with decreased oxygen affinity (HBB:c.317T>A, "Hemoglobin St. George") in a healthy child with low oxygen saturations and anemia. American journal of hematology, 96(12), E448-E450.

Abstract

  1. Stivers N, Rets A (2020). Case of T-cell large granular lymphocytic leukemia with clonal drift and immunophenotype normalization. 144(9s1), e65.
  2. McMurtry V, Rets A (2019). Comparison of MYC Break-Apart and IGH/MYC Dual-Fusion Probe Sensitivity for Detection of MYC Rearrangements in Large B-Cell Lymphomas. 143(9), e68.
  3. Mohlman J, Rets A (2019). Fibrin-Associated Diffuse Large B-Cell Lymphoma Occurring as a Pararenal Pseudocyst. 152(S1), S105.
  4. Rets AV, Toydemir RM, Hussong JW, Salama M (2016). Immunophenotypic and cytogenetic evolution pattern of the neoplastic cells in relapsed multiple myeloma after stem cell transplant. 29(S2),
  5. Tripp SR, Rets AV, Tsewang T, Salama M (2016). Immunohistochemical detection of Calreticulin mutations in bone marrow biopsy samples from patients with myeloproliferative neoplasms.
  6. Rets AV, Yaoping Z, Gottesman R (2015). Monotypic B-Cell Population and Chromosomal Aberration in Histologically Benign Lymph Node. 139(10), e53.
  7. Rets AV, Verma V, Gottesman S (2014). Aggressive marginal zone lymphoma. 139(9), e2-e183.
  8. Rets AV, Gupta R, Rao (2013). Rare Variant Translocation in a Pediatric Case of Chronic Myelogenous Leukemia. 137(10), 1363.
  9. Kruchkov AN, Rets A (2004). Mast Cells in Regional Lymph Nodes in Radiation-treated Breast Carcinoma. (6), 195-200.
  10. Friend GG, Kruchkov AN, Rets A (2004). Morphologic Characteristic of Axillary Lymph Node Sinuses in Radiation-treated Breast Carcinoma. (6), 236-241.
  11. Rets A (2003). Radiogenic Changes in the Axillary Lymph Nodes Capsule in Breast Carcinoma. (30), 51-53.
  12. Kruchkov AN, Rets A (2003). Quantitative Patterns in Tumor Cell Apoptosis in Different Histological Variants of Breast Carcinoma. (30), 25-26.
  13. Anisimov GV, Kruchkov AN, Rets A (2003). Mucoid degeneration of stroma in patients with breast carcinoma. (30), 27-28.
  14. Friend GG, Kruchkov AN, Patrikeev IA, Rets AV, Urlov R (2003). Methods of Tumor Cell Nuclear Polymorphism Computer-based Evaluation. (30), 40-42.
  15. Rets A (2002). Radiogenic Apoptosis of Breast Carcinoma Cells in Primary Tumor and Regional Metastases. (36), 129-30.
  16. George TI, Karner KH, Moser, KI, Rets A, Reiter A, Radia DH, Deininger M, Lin HM, Dimitrijevi¿ S, Cossetti C, DeAngelo D Responses to Avapritinib in patients with advanced systemic mastocytosis: histopathologic analyses from Explorer and Pathfinder clinical studies.

Other

  1. Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter M (2025). Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. American journal of clinical dermatology, 26(5), 851.

Video/Film/CD/Web/Podcast

  1. N Leonar (2021). Soft Tissue Sarcoma for ARUP Consult.
  2. Rets A (2020). 32-year old man with chronic microcytic anemia/ Hb Constant Spring and Hb H disease.
  3. Rets A (2019). 32-year-old man with chronic microcytic anemia.